Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

15.66 +0.14 (+0.90%)
Streaming Delayed Price Updated: 1:35 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CeriBell, Inc. - Common Stock

Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
From Ceribell
Via GlobeNewswire
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) Technology 
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference
From Ceribell
Via GlobeNewswire
Ceribell Reports First Quarter 2025 Financial Results
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference
From Ceribell
Via GlobeNewswire
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
From Ceribell
Via GlobeNewswire
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025
From Ceribell
Via GlobeNewswire
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies 
From Ceribell
Via GlobeNewswire
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
From Ceribell
Via GlobeNewswire
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Ceribell
Via GlobeNewswire
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing
From Ceribell
Via GlobeNewswire
Ceribell Reports Third Quarter 2024 Financial Results
From Ceribell
Via GlobeNewswire
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
From Ceribell
Via GlobeNewswire
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
From Ceribell
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.